UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network

Nucleic acids research, 2011-05, Vol.39 (9), p.3864

2011

Volltextzugriff (PDF)

Clinicopathologic characteristics of poorly differentiated chordoma

Modern pathology, 2018-08, Vol.31 (8), p.1237-1245

2018

Volltextzugriff (PDF)

Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma

BioMed research international, 2014-01, Vol.2014, p.780521-8

2014

Volltextzugriff (PDF)

dbDEMC: a database of differentially expressed miRNAs in human cancers

BMC genomics, 2010-12, Vol.11 Suppl 4 (S4), p.S5-S5, Article S5

2010

Volltextzugriff (PDF)

Coffee and cancer risk: A meta-analysis of prospective observational studies

Scientific reports, 2016-09, Vol.6 (1), p.33711-33711, Article 33711

2016

Volltextzugriff (PDF)

Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis

Journal of hepatology, 2014-10, Vol.61 (4), p.840-849

2014

Volltextzugriff (PDF)

Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST

Radiotherapy and oncology, 2019-08, Vol.137, p.61-70

2019

Volltextzugriff (PDF)

Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer

Cancers, 2024-01, Vol.16 (3), p.556

2024

Volltextzugriff (PDF)

187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A211-A213

2023

Volltextzugriff (PDF)

Extraskeletal osteosarcoma: A large series treated at a single institution

Rare tumors, 2018, Vol.10, p.2036361317749651-2036361317749651

2018

Volltextzugriff (PDF)

A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy

Journal of surgical oncology, 2009-11, Vol.100 (6), p.488-493

2009

Volltextzugriff (PDF)

Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China

The American journal of surgery, 2012-06, Vol.203 (6), p.741-750

2012

Volltextzugriff (PDF)

Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution

Sarcoma, 2019, Vol.2019, p.9069272-10

2019

Volltextzugriff (PDF)

Identification of recurrence related microRNAs in hepatocellular carcinoma after surgical resection

International journal of molecular sciences, 2013-01, Vol.14 (1), p.1105-1118

2013

Volltextzugriff (PDF)

MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development

Hepatology research, 2017-01, Vol.47 (1), p.80-94

2017

Volltextzugriff (PDF)

The role and clinical implications of microRNAs in hepatocellular carcinoma

Science China. Life sciences, 2012-10, Vol.55 (10), p.906-919

2012

Volltextzugriff (PDF)

Progression and prospects of translational medicine in China

Science China. Life sciences, 2012-11, Vol.55 (11), p.1022-1025

2012

Volltextzugriff (PDF)

phylogenetic analysis of the ubiquitin superfamily based on sequence and structural information

Molecular biology reports, 2014-09, Vol.41 (9), p.6083-6088

2014

Volltextzugriff (PDF)

NONCODE v3.0: integrative annotation of long noncoding RNAs

Nucleic acids research, 2012-01, Vol.40 (Database issue), p.D210

2012

Volltextzugriff (PDF)

Biomarker analysis from a phase I/I1b study of regorafenib and nivolumab (rego/nivo) in microsatellite stable (MSS) colorectal cancer (CRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.188-188

2023

Volltextzugriff (PDF)

Mps1/TTK: a novel target and biomarker for cancer

Journal of drug targeting, 2017-02, Vol.25 (2), p.112-118

2017

Volltextzugriff (PDF)

Biomarker analysis to predict response in patients with metastatic mismatch repair proficient colorectal cancer treated with regorafenib and nivolumab

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.228-228

2023

Volltextzugriff (PDF)

Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?

Cancer Immunology, Immunotherapy, 2023-07, Vol.72 (7), p.2521-2527

2023

Volltextzugriff (PDF)

The impact of COVID-19 infection on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2525-2525

2022

Volltextzugriff (PDF)

Conditional survival of patients with nonmetastatic bone osteosarcoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e23511-e23511

2020

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(96)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network

Clinicopathologic characteristics of poorly differentiated chordoma

Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma

dbDEMC: a database of differentially expressed miRNAs in human cancers

Coffee and cancer risk: A meta-analysis of prospective observational studies

Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis

Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST

Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer

187 Immune checkpoint inhibitor (CPI) efficacy in gastrointestinal tumors with microsatellite-stable with high tumor mutational burden (MSS-TMB-H) compared to microsatellite instability-high (MSI-H)

Extraskeletal osteosarcoma: A large series treated at a single institution

A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy

Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China

Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution

Identification of recurrence related microRNAs in hepatocellular carcinoma after surgical resection

MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development

The role and clinical implications of microRNAs in hepatocellular carcinoma

Progression and prospects of translational medicine in China

phylogenetic analysis of the ubiquitin superfamily based on sequence and structural information

NONCODE v3.0: integrative annotation of long noncoding RNAs

Biomarker analysis from a phase I/I1b study of regorafenib and nivolumab (rego/nivo) in microsatellite stable (MSS) colorectal cancer (CRC)

Mps1/TTK: a novel target and biomarker for cancer

Biomarker analysis to predict response in patients with metastatic mismatch repair proficient colorectal cancer treated with regorafenib and nivolumab

Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?

The impact of COVID-19 infection on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors

Conditional survival of patients with nonmetastatic bone osteosarcoma

Suchergebnisse filtern